Expanding the Mutational Landscape and Clinical Phenotype of CHD2-Related Encephalopathy
Authors:
- Angela Clara-HwangACAngela Clara-Hwang
- Stefani StefaniSSStefani Stefani
- Tracy LauTLTracy Lau
- Marcello ScalaMSMarcello Scala
- Busra AynekinBABusra Aynekin
- Pia BernardoPBPia Bernardo
- Francesca MadiaFMFrancesca Madia
- Sophia BakhtadzeSBSophia Bakhtadze
- Rauan KaiyrzhanovRKRauan Kaiyrzhanov
- Reza MaroofianRMReza Maroofian
- Federico ZaraFZFederico Zara
- Varunvenkat M. SrinivasanVSVarunvenkat M. Srinivasan
Open Access
- 1 August 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology Genetics
- Vol. 10 (4) , e200168
Abstract
To present a case series of novel CHD2 variants in patients presenting with genetic epileptic and developmental encephalopathy. CHD2 gene encodes an ATP-dependent enzyme, chromodomain helicase DNA-binding protein 2, involved in chromatin remodeling. Pathogenic variants in CHD2 are linked to early-onset conditions such as developmental and epileptic encephalopathy, drug-resistant epilepsies, and neurodevelopmental disorders. Approximately 225 diagnosed patients from 28 countries exhibit various allelic variants in CHD2, including small intragenic deletions/insertions and missense, nonsense, and splice site variants. We present the molecular and clinical characteristics of 17 unreported individuals from 17 families with novel pathogenic or likely pathogenic variants in CHD2. All individuals presented with severe global developmental delay, childhood-onset myoclonic epilepsy, and additional neuropsychiatric features, such as behavioral including autism, ADHD, and hyperactivity. Additional findings include abnormal reflexes, hypotonia and hypertonia, motor impairment, gastrointestinal problems, and kyphoscoliosis. Neuroimaging features included hippocampal signal alterations (4/10), with additional volume loss in 2 cases, inferior vermis hypoplasia (7/10), mild cerebellar atrophy (4/10), and cerebral atrophy (1/10). Our study broadens the geographic scope of CHD2-related phenotypes, providing valuable insights into the prevalence and clinical characteristics of this genetic disorder in previously underrepresented populations.Keywords
This publication has 20 references indexed in Scilit:
- Morphometric network-based abnormalities correlate with psychiatric comorbidities and gene expression in PCDH19-related developmental and epileptic encephalopathyTranslational Psychiatry, 2024
- Clinical analysis of CHD2 gene mutations in pediatric patients with epilepsyPediatric Investigation, 2022
- Dual and Opposing Roles of MicroRNA-124 in Epilepsy Are Mediated through Inflammatory and NRSF-Dependent Gene NetworksCell Reports, 2016
- Hippocampal Sclerosis: Causes and PreventionSeminars in Neurology, 2015
- CHD2variants are a risk factor for photosensitivity in epilepsyBrain, 2015
- Human CHD2 Is a Chromatin Assembly ATPase Regulated by Its Chromo- and DNA-binding DomainsJournal of Biological Chemistry, 2015
- CHD2 mutations in Lennox–Gastaut syndromeEpilepsy & Behavior, 2014
- De Novo Loss-of-Function Mutations in CHD2 Cause a Fever-Sensitive Myoclonic Epileptic Encephalopathy Sharing Features with Dravet SyndromeThe American Journal of Human Genetics, 2013
- Chromatin remodeling by the CHD7 protein is impaired by mutations that cause human developmental disordersProceedings of the National Academy of Sciences, 2012
- The Chd family of chromatin remodelersMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2007